Identifying demographic, social and clinical predictors of biologic therapy effectiveness in psoriasis: a multicentre longitudinal cohort study — Richard B. Warren (2018) | RDL Network
Identifying demographic, social and clinical predictors of biologic therapy effectiveness in psoriasis: a multicentre longitudinal cohort study
Article 2018 en
Authors
RW
Richard B. Warren
AM
Antonia Marsden
BT
Barbara Tomenson
Abstract
1 min read
Psoriasis phenotype and potentially modifiable factors are associated with poor outcomes with biologics, underscoring the need for lifestyle management. Effect sizes suggest that these factors alone cannot inform treatment selection.
K.J. Mason, Oras Alabas, Nick Dand, Richard B. Warren, Nick J. Reynolds, Juliet N. Barker, Zenas Z N Yiu, Catherine Smith, Christopher Em Griffiths, Juliet N. Barker, Simon Morrison, Anthony Bewley, Ian Evans, Christopher Em Griffiths, Shehnaz Ahmed, Brian Kirby, Elise Kleyn, Philip Laws, Philip Hampton, Oras Alabas, Kathleen McElhone, Zenas Z N Yiu, Teena Mackenzie, Tess McPherson, Ruth Murphy, Anthony D. Ormerod, Shernaz Walton, Nick J. Reynolds, Alexa R. Shipman, Christina Ye, Olivia Hughes, Richard B. Warren, Fiona Browne, Ian Evans, Brian Kirby, Linda Lawson, Philip Laws, Teena Mackenzie, Tess McPherson, Ruth Murphy, Caroline Owen, Eleanor Pearson, Josh Richards, Richard B. Warren
Su M. Lwin, Shane Solanky, Cristiano Scottà, Chiara Giacomini, Shir Azrielant, Isabella Tosi, Atheer Al-Haddabi, Emelia Duarte-Williamson, Hannah Dawe, Sarah Walsh, John A. McGrath, Giovanna Lombardi, Francesco Dazzi, Paola Di Meglio, Christopher Em Griffiths
Nina Wilkinson, Teresa Tsakok, Nick Dand, Karien Bloem, Michael Duckworth, David Baudry, Angela Pushpa‐Rajah, Christopher Em Griffiths, Nick J. Reynolds, Juliet N. Barker, Richard B. Warren, A. David Burden, Theo Rispens, Deborah Stocken, Catherine Smith
.webp){kind=small}
Discussion(0)
No comments yet. Be the first to comment.